Trimedoxime bromide
 | |
| Clinical data | |
|---|---|
| Routes of administration | Intramuscular injection |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Elimination half-life | 2 hours (mean) |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ECHA InfoCard | 100.000.276  |
| Chemical and physical data | |
| Formula | C15H18Br2N4O2 |
| Molar mass | 446.143 g·mol−1 |
Trimedoxime bromide (INN), also known as dipyroxime or TMB-4, is an oxime used in the treatment of organophosphate poisoning.
References
| Nervous system |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Circulatory system |
| ||||||||||||||
| Other |
| ||||||||||||||
| Emetic |
| ||||||||||||||
| |||||||||||||||
| Enzyme (modulators) |
| ||||||
|---|---|---|---|---|---|---|---|
| Transporter (modulators) |
| ||||||
| Release (modulators) |
| ||||||
See also: Receptor/signaling modulators • Muscarinic acetylcholine receptor modulators • Nicotinic acetylcholine receptor modulators | |||||||
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.